Dandona P, Nix D, Wilson M F, Aljada A, Love J, Assicot M, Bohuon C
Department of Medicine, Millard Fillmore Hospitals, State University of New York, Buffalo 14209.
J Clin Endocrinol Metab. 1994 Dec;79(6):1605-8. doi: 10.1210/jcem.79.6.7989463.
As procalcitonin concentrations have been shown to be elevated in patients with septicemia and gram-negative infections in particular, we proceeded to investigate the effect of endotoxin, a product of gram-negative bacteria, on procalcitonin concentrations in normal human volunteers. Endotoxin from Escherichia coli 0113:H10:k, was injected i.v. at a dose of 4 mg/kg BW into these healthy volunteers. Blood samples were obtained before and 1, 2, 4, 6, 8, and 24 h after injection of the endotoxin. Each patient's cardiovascular and overall clinical status was monitored over this period. The patients developed chills and rigors, myalgia, and fever between 1-3 h. Tumor necrosis factor-alpha levels increased sharply at 1 h and peaked at 90 min, reaching the baseline concentration thereafter by 6 h. Interleukin-6 levels increased more gradually, peaking at 3 h and reaching the baseline concentration at 8 h. The procalcitonin concentration, which was undetectable (< 10 pg/mL) at 0, 1, and 2 h, was detectable at 4 h and peaked at 6 h, maintaining a plateau through 8 and 24 h (4 ng/mL). There was no elevation of calcitonin concentrations, which remained below 10 pg/mL, the lowest sensitivity of the assay. Procalcitonin was measured by a two-antibody immunoradiometric assay specific for this peptide, with no cross-reactivity with calcitonin, katacalcin, or calcitonin gene-related peptide. We conclude that endotoxin induces the release of procalcitonin systemically, that this increase is not associated with an increase in calcitonin, and that the increase in procalcitonin associated with septicemia in patients may be mediated through the effect of endotoxin described here. Whether procalcitonin participates in the mechanisms underlying inflammation remains to be investigated.
由于已证明败血症患者,尤其是革兰氏阴性菌感染患者的降钙素原浓度会升高,我们着手研究革兰氏阴性菌产物内毒素对正常人类志愿者降钙素原浓度的影响。将来自大肠杆菌0113:H10:k的内毒素以4mg/kg体重的剂量静脉注射到这些健康志愿者体内。在注射内毒素前以及注射后1、2、4、6、8和24小时采集血样。在此期间监测每位患者的心血管和整体临床状况。患者在1至3小时之间出现寒战、颤抖、肌痛和发热。肿瘤坏死因子-α水平在1小时时急剧升高,在90分钟时达到峰值,此后在6小时时恢复到基线浓度。白细胞介素-6水平升高较为缓慢,在3小时时达到峰值,在8小时时恢复到基线浓度。降钙素原浓度在0、1和2小时时无法检测到(<10pg/mL),在4小时时可检测到,并在6小时时达到峰值,在8至24小时内维持在平台期(4ng/mL)。降钙素浓度没有升高,仍低于10pg/mL,即该检测方法的最低灵敏度。降钙素原通过针对该肽的双抗体免疫放射分析进行测量,与降钙素、降钙素基因相关肽或降钙素原无交叉反应。我们得出结论,内毒素可诱导降钙素原在全身释放,这种升高与降钙素的升高无关,并且患者败血症相关的降钙素原升高可能通过此处所述的内毒素作用介导。降钙素原是否参与炎症的潜在机制仍有待研究。